432PDPrognostic impact of RNA expression profile (EP) in the phase III DECISION trial for patients with advanced radioactive-iodine refractory differentiated thyroid cancer (DTC)
Matos, I., Mancuso, F., Iglesias, C., Nuciforo, P., Zafón, C., Palmer, H.G., Ogbah, Z., Muños, L., Villacampa Javierre, G., Peña, C., Brose, M.S., Schlumberger, M., Vivancos, A., Capdevila, J.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx368.005
Date:
September, 2017
File:
PDF, 101 KB
english, 2017